发明名称 HETEROCYCLIC ITK INHIBITORS FOR TREATING INFLAMMATION AND CANCER
摘要 Disclosed herein are heterocyclic compounds and compositions useful in the treatment of ITK mediated diseases, such as inflammation, having the structure of Formula (I):;;wherein R1, R2, and X are as defined in the detailed description. Methods of inhibition of ITK activity in a human or animal subject are also provided.
申请公布号 US2016213653(A1) 申请公布日期 2016.07.28
申请号 US201615005627 申请日期 2016.01.25
申请人 Confluence Life Sciences, Inc. 发明人 Jacobsen Eric Jon;Blinn James Robert;Springer John Robert;Hockerman Susan L.
分类号 A61K31/437;C07D519/00;A61K31/5377;A61K31/506;C07D471/04;A61K45/06 主分类号 A61K31/437
代理机构 代理人
主权项 1. A compound, or a pharmaceutically acceptable salt, hydrate or solvate thereof, of Formula (I): wherein: R1 is chosen from mono- and bicyclic aryl and heteroaryl, wherein R1 may be optionally substituted with one or more R3 substituents; R2 is chosen from heterocycloalkyl, aryl, and heteroaryl, each of which is substituted with one R4 substituent, and any of which may be further optionally substituted with one or more R8 substituents, or alternatively R2 is NR12R13; each R3 is independently chosen from hydrogen, hydroxyl, cyano, C1-6alkyl, hydroxyC1-4alkyl, C1-6alkoxyalkyl, arylC1-6alkyl, arylC1-6alkoxy, heteroarylC1-6alkyl, heteroarylC1-6alkoxy, aryloxyC1-6alkyl, heteroaryloxyC1-6alkyl, aryloxyC1-6alkyl, heteroaryloxyC1-6alkyl, cyclopropylC1-4alkyl, cyclopropylC1-4alkoxy, cyclopropoxyC1-4alkyl, C1-4alkylamino, C1-4alkylarylamino, C1-4alkylheteroarylamino, di(C1-4alkyl)amino, —C(O)NR6R6′, C1-4alkanoyl, —C(O)aryl, —C(O)heteroaryl, —C(O)NHaryl, —C(O)NHheteroaryl, trifluoromethyl, and halo, wherein aryl and heteroaryl may be optionally substituted with R9; R4 is chosen from NR5R6, —(CH2)nCR7═CR9C(O)CH3, —(CH2)nCR7═CR9C(O)NR7R7′, and —(CH2)nC7═CR9CN; R5 is chosen from cyano, —C(O)CF3, —C(O)CH═CH2, —C(O)CR7═CH2, —C(O)CH═CHR7, —C(O)CR7═CHR7, —C(O)CH═CR7R7′, —C(O)CH═CHCH2R8, —C(O)CH═CHC(O)CH2R8, —COC(CN)═CHR6, —C(O)(C(O)NH2)═CHR6, C(O)alkynylR7, —S(O)2CH═CH2, —(CH2)mCR7═CR9C(O)CH3, —(CH2)mCR7═CR9C(O)NR7R7′, and —(CH2)mCR7═CR9CN; R6 and R6′ are each independently chosen from hydrogen, C1-4alkyl, C3-7cycloalkylalkyl, and phenylC1-4alkyl; R7 and R7′ are each independently chosen from hydrogen, cyano, C1-4alkyl, hydroxyC1-4alkyl, C1-4alkoxyalkyl, C3-7cycloalkyl, C3-7heterocycloalkyl, C3-7heterocycloalkylalkyl, (NR6R6′)C1-4alkyl, aryl, and heteroaryl, wherein aryl and heteroaryl may be optionally substituted with one or more R9; R8 is chosen from hydrogen, halo, cyano, C1-4alkyl, arylC1-4alkyl, heteroarylC1-4alkyl, C3-7cycloalkyl, hydroxyC1-6alkyl, heterocycloalkylC1-4alkyl, C3-7heterocycloalkyl, hydroxyl, C1-4alkoxy, C3-7cycloalkoxy, C3-7cycloalkoxyalkyl, heteroaryloxy, aryloxy, (NR6R6′)alkyl, arylalkoxy, C1-4alkoxyC1-4alkyl, amino, C1-4alkylamino, di(C1-4alkyl)amino, trifluoromethyl, aryl, and heteroaryl, wherein alkyl, heterocycloalkyl, aryl and heteroaryl may be optionally substituted with one or more R9; R9 is chosen from hydrogen, halo, hydroxyl, C1-4 alkyl, cyano, trifluoromethyl, alkanoyl, amino, amido, and aryl; R10 is chosen from hydrogen, C1-4alkyl, C1-4alkoxy, halo, trifluoromethyl, and cyano; R11 is chosen from hydrogen, C1-4alkyl, C3-7cycloalkylalkyl, heterocycloalkylalkyl, arylC1-4alkyl, and heteroarylC1-4alkyl, wherein aryl and heteroaryl may be optionally substituted with one or more R9; R12 is a nitrogen-containing C3-7heterocycloalkyl, wherein said nitrogen is further substituted by R5; R13 is chosen from hydrogen, C1-4alkyl, and C3-7cycloalkylalkyl; X is N or CR11; m is an integer chosen from 1, 2 and 3; and n is an integer chosen from 0, 1, 2, and 3.
地址 St. Louis MO US